Small invasive colon cancer with systemic metastasis: A case report

BMC Gastroenterology

Yutaka Saito⁴  Ryoji Kushima²  Takahisa Matsuda⁴  Taku Sakamoto⁴  Tsutomu Kouno¹  Ken Kato³  Takeshi Nakajima⁴  Minori Matsumoto⁴ 

[1] Department of Medical Oncology, Sasaki Foundation Kyoundo Hospital, 1-8 Kanda Surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan;Pathology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan;Gastrointestinal Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan;Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan

关键词: systemic metastasis;    CK7;    CK20;    CDX2;    Nonpolypoid colorectal cancer;   

Others  :  1114508
DOI  :  10.1186/1471-230X-11-59

 received in 2011-01-07, accepted in 2011-05-20,  发布年份 2011

【 授权许可】

   
2011 Matsumoto et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin 60(5):277-300.
• [2]Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 1988, 319(9):525-532.
• [3]Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, et al.: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993, 329(27):1977-1981.
• [4]Rembacken BJ, Fujii T, Cairns A, Dixon MF, Yoshida S, Chalmers DM, Axon AT: Lancet. 2000, 355(9211):1211-1214.
• [5]Nakajima T, Saito Y, Matsuda T, Hoshino T, Yamamoto S, Tamura T, Moriya Y, Saito D: Minute depressed-type submucosal invasive cancer-5 mm in diameter with intermediate lymph-node metastasis: report of a case. Dis Colon Rectum 2007, 50(5):677-681.
• [6]Matsuda T, Saito Y, Fujii T, Uraoka T, Nakajima T, Kobayashi N, Emura F, Ono A, Shimoda T, Ikematsu H, et al.: Size does not determine the grade of malignancy of early invasive colorectal cancer. World J Gastroenterol 2009, 15(22):2708-2713.
• [7]Shimoda T, Ikegami M, Fujisaki J, Matsui T, Aizawa S, Ishikawa E: Early colorectal carcinoma with special reference to its development de novo. Cancer 1989, 64(5):1138-1146.
• [8]Update on the paris classification of superficial neoplastic lesions in the digestive tract Endoscopy 2005, 37(6):570-578.
• [9]Matsuda T, Fujii T, Saito Y, Nakajima T, Uraoka T, Kobayashi N, Ikehara H, Ikematsu H, Fu KI, Emura F, et al.: Efficacy of the invasive/non-invasive pattern by magnifying chromoendoscopy to estimate the depth of invasion of early colorectal neoplasms. Am J Gastroenterol 2008, 103(11):2700-2706.
• [10]Yao T, Tsutsumi S, Akaiwa Y, Takata M, Nishiyama K, Kabashima A, Tsuneyoshi M: Phenotypic expression of colorectal adenocarcinomas with reference to tumor development and biological behavior. Jpn J Cancer Res 2001, 92(7):755-761.
• [11]Le Chevalier T, Cvitkovic E, Caille P, Harvey J, Contesso G, Spielmann M, Rouesse J: Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. Arch Intern Med 1988, 148(9):2035-2039.
• [12]Mayordomo JI, Guerra JM, Guijarro C, Garcia-Prats MD, Gomez A, Lopez-Brea M, Gonzalez R, Hergueta P, Lopez-Pino MA, Martinez-Tello F, et al.: Neoplasms of unknown primary site: a clinicopathological study of autopsied patients. Tumori 1993, 79(5):321-324.
• [13]Abbruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Lenzi R, Frost P: Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 1994, 12(6):1272-1280.
• [14]Culine S, Kramar A, Saghatchian M, Bugat R, Lesimple T, Lortholary A, Merrouche Y, Laplanche A, Fizazi K: Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site. J Clin Oncol 2002, 20(24):4679-4683.
• [15]van de Wouw AJ, Janssen-Heijnen ML, Coebergh JW, Hillen HF: Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer 2002, 38(3):409-413.
• [16]Tot T: Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Cancer 1999, 85(1):171-177.
• [17]Tot T: Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer 2002, 38(6):758-763.